California Assembly Bill AB1063

California 2025-2026 Regular Session

• Introduced: 2/20/25
• Refer: 3/24/25
• Failed: 2/2/26

Caption

An act to amend Section 125010 of, and to add Section 125003 to, the Health and Safety Code, relating to public health.

Summary

AB 1063 would create a narrow statutory rule governing when the California Department of Public Health may disclose a newborn’s physical blood test, or residual newborn screening specimen, to law enforcement. The bill allows disclosure only in response to a search warrant whose purpose is to obtain DNA from a missing person suspected to be a victim of homicide, child abuse resulting in death, or manslaughter, for comparison against the Department of Justice Missing Persons DNA Database and possible future identification of that person. The bill also expressly prohibits law enforcement from seeking or using a warrant for the newborn blood sample for other purposes, including identifying suspects, building a DNA database of suspects or nonsuspects, or establishing guilt in a criminal case. In addition, AB 1063 would require the department’s annual newborn screening report to the Legislature to include the number of search warrants received and the number of disclosures granted under this new authority.

Impact

AB 1063 would amend the Health and Safety Code by adding Section 125003 and revising Section 125010. It would create a limited exception to the confidentiality protections surrounding newborn screening and biobank specimens, while preserving the general rule that such information remains confidential except for the specific missing-person identification purpose described in the bill. The measure would also expand the department’s annual reporting obligations beginning July 1, 2026, by adding warrant and disclosure statistics to the existing newborn screening program report.

Sentiment

Based on the bill text and available legislative context, the measure appears to be framed as a targeted public-safety and transparency bill rather than a broad expansion of law-enforcement access. The absence of recorded committee testimony or votes makes it difficult to identify detailed support or opposition, but the bill’s narrow scope suggests an attempt to balance investigative needs with privacy protections. The inclusion of explicit limits on law-enforcement use and reporting requirements indicates sensitivity to concerns about misuse of newborn screening specimens.

Contention

The main point of contention is likely to be privacy and civil-liberties concerns versus the need to assist missing-person investigations. Supporters would likely emphasize the bill’s limited use case for identifying victims of homicide, child abuse resulting in death, or manslaughter, and its prohibition on using the sample to investigate suspects or build DNA databases. Opponents or skeptics would likely focus on the fact that newborn blood samples are collected for public health purposes and are traditionally treated as confidential, raising concerns about compelled disclosure, scope creep, and the potential for law-enforcement access to sensitive biological material.